Federated Hermes’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-166
Closed -$6K 2471
2020
Q1
$6K Sell
166
-29
-15% -$1.33K ﹤0.01% 1923
2019
Q4
$9K Sell
195
-154
-44% -$6.67K ﹤0.01% 1918
2019
Q3
$14K Sell
349
-834
-70% -$36K ﹤0.01% 1858
2019
Q2
$57K Sell
1,183
-153,939
-99% -$8.09M ﹤0.01% 1659
2019
Q1
$9.71M Buy
155,122
+19,353
+14% +$1.33M 0.02% 575
2018
Q4
$8.11M Buy
135,769
+91,102
+204% +$5.47M 0.02% 569
2018
Q3
$2.88M Buy
44,667
+44,139
+8,360% +$2.46M 0.01% 966
2018
Q2
$24K Buy
528
+70
+15% +$2.79K ﹤0.01% 1783
2018
Q1
$14K Buy
458
+24
+6% +$789 ﹤0.01% 1827
2017
Q4
$13K Sell
434
-203
-32% -$5.88K ﹤0.01% 1849
2017
Q3
$21K Buy
637
+132
+26% +$4.57K ﹤0.01% 1752
2017
Q2
$17K Buy
505
+65
+15% +$1.94K ﹤0.01% 1779
2017
Q1
$13K Buy
440
+367
+503% +$9.09K ﹤0.01% 1790
2016
Q4
$2K Sell
73
-1,023
-93% -$20K ﹤0.01% 2036
2016
Q3
$20K Buy
1,096
+52
+5% +$981 ﹤0.01% 1754
2016
Q2
$17K Buy
+1,044
New +$15.4K ﹤0.01% 1762
2016
Q1
Sell
-267
Closed -$3K 2271
2015
Q4
$3K Sell
267
-39
-13% -$493 ﹤0.01% 1949
2015
Q3
$4K Sell
306
-231
-43% -$2.94K ﹤0.01% 1824
2015
Q2
$5K Sell
537
-287
-35% -$2.66K ﹤0.01% 1814
2015
Q1
$7K Buy
824
+323
+64% +$3.26K ﹤0.01% 1827
2014
Q4
$5K Buy
+501
New +$4.3K ﹤0.01% 1856
2014
Q3
Sell
-86
Closed -$1K 2138
2014
Q2
$1K Buy
+86
New +$684 ﹤0.01% 1957

Other funds holding BEAT

Federated Hermes's BEAT Position: Q2 2020 in Review

Federated Hermes sold out of BioTelemetry, Inc. (BEAT) in Q2 2020, closing a stake of 166 shares — an estimated $6K sold.

Federated Hermes first reported a position in BEAT in Q2 2014 and held it in 22 quarters. The position peaked at $9.71M in Q1 2019. 215 funds tracked by Wall St. Rank hold BEAT as of Q2 2020.

  • Federated Hermes reported no remaining BioTelemetry, Inc. position as of Q2 2020 after selling out during the quarter.
  • Federated Hermes sold 166 BioTelemetry, Inc. shares in Q2 2020, an estimated $6K.
  • Federated Hermes first reported a position in BioTelemetry, Inc. in Q2 2014 and held it in 22 quarters.
  • Federated Hermes's BioTelemetry, Inc. position peaked at $9.71M in Q1 2019.
  • 215 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2020.

Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.